Investigators assessed patients with early-onset cancer for their awareness of potential cancer-related infertility risk.

Researchers investigated inotuzumab ozogamicin for children with CD22-positive, very high-risk first B-cell acute lymphoblastic leukemia relapse.

In this study, researchers studied the efficacy and safety of concurrent and consolidative durvalumab plus definitive radiotherapy without chemotherapy.

Freenome's newly approved blood test offers clinicians an alternative screening option for average-risk adults aged 45 and older.

Investigators evaluated evidence supporting the use and cost effectiveness of oral targeted anticancer medications.

Oncology researchers are actively exploring ways to expand mRNA platforms and develop potential universal cancer vaccines.

Investigators evaluated the relationship between overall survival and discontinuing immune checkpoint inhibitor therapy due to immunological toxicity in patients with metastatic melanoma.

Younger age, White race, higher physical activity, and alcohol use tied to increased prevalence of outdoor tanning in US women. (HealthDay News) — More than one-third of women and one-quarter of men ...

Investigators compared survival outcomes for patients with primary rectal adenocarcinoma managed with a watch-and-wait strategy versus patients who received total mesorectal excision.

Researchers evaluated which specific cancers contributed to shrinking the cancer mortality gap between Black and White patients from 1991-1995 to 2019-2023.

Investigators estimated the 10-year survival gains and health care cost savings that might result from nationwide implementation of evidence-based tobacco treatment for survivors and patients with ...

(HealthDay News) — The global morbidity gap increased from 1990 to 2023, according to a study published in the August issue of The Lancet Public Health.